{"id":78,"date":"2005-11-15T19:18:00","date_gmt":"2005-11-16T02:18:00","guid":{"rendered":"https:\/\/stockherd.com\/moosepond\/?p=78"},"modified":"2005-11-15T19:18:00","modified_gmt":"2005-11-16T02:18:00","slug":"sold-lincare-holdings","status":"publish","type":"post","link":"https:\/\/stockherd.com\/moosepond\/2005\/11\/15\/sold-lincare-holdings\/","title":{"rendered":"Sold Lincare Holdings"},"content":{"rendered":"<div class=\"box\">\n<a href=\"https:\/\/stockherd.com\/moosepond\/files\/ssg\/lncr_20051108.pdf\">SSG and PERT A (11-08-2005)<\/a><br \/>\n&nbsp;|&nbsp;<br \/>\n<a href=\"http:\/\/www.google.com\/search?sourceid=navclient&#038;ie=UTF-8&#038;oe=UTF-8&#038;q=stocks%3A+lncr\">Google &#8220;stocks: lncr&#8221;<\/a><br \/>\n&nbsp;|&nbsp;<br \/>\n<a href=\"http:\/\/www.lincare.com\">Company Website<\/a>\n<\/div>\n<p>We sold LNCR today and redeployed the cash.  LNCR&#8217;s revenue and earnings growth has declined over the past two years.  See PERT A graph (above).  Lower federal reimbursement for supplemental oxygen has cut into its margins.  We used the above stock selection guide in making this decision.<br \/>\n<!--more--><br \/>\n<strong>Company Description:<\/strong>  Lincare Holdings is a leading provider of oxygen and respiratory services to home-based patients, who typically suffer from chronic obstructive pulmonary disease, such as emphysema, chronic bronchitis, or asthma. Products and services incl.: liquid oxygen systems, oxygen concentrators, nebulizers, respiratory medications, noninvasive ventilation, apnea monitors, ventilators, and continuous positive airway pressure devices. Also provides infusion therapy and home med. equip. 2003 dep. rate: 12.3%. Has about 7,375 empls. Off.\/dir. control 6.4% of com.; Capital Grp. Intl., 10.4%; GE Asset Mgmt., 7.4% (4\/04 proxy). Chrmn., CEO &#038; Pres.: John P. Byrnes. Inc: DE. Add: 19337 US 19 North, Ste 500, Clearwater, FL 34624. Tel: 727-530-7700. Internet: <a href=\"http:\/\/www.lincare.com\">www.lincare.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SSG and PERT A (11-08-2005) &nbsp;|&nbsp; Google &#8220;stocks: lncr&#8221; &nbsp;|&nbsp; Company Website We sold LNCR today and redeployed the cash. LNCR&#8217;s revenue and earnings growth has declined over the past two years. See PERT A graph (above). Lower federal reimbursement for supplemental oxygen has cut into its margins. We used the above stock selection guide [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_jetpack_memberships_contains_paid_content":false,"_links_to":"","_links_to_target":""},"categories":[9,10],"tags":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/posts\/78"}],"collection":[{"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/comments?post=78"}],"version-history":[{"count":0,"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/posts\/78\/revisions"}],"wp:attachment":[{"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/media?parent=78"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/categories?post=78"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stockherd.com\/moosepond\/wp-json\/wp\/v2\/tags?post=78"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}